CONDITIONALLY PATHOGENIC MICROFLORA IN PATIENTS WITH BACTERIAL VAGINOSIS
Main Article Content
Abstract
The aim of the research. To study the composition of vaginal microflora in patients with bacterial vaginosis (BV), to determine the role of conditionally pathogenic microorganisms in the development of recurrence of this disease.
Materials and methods. The investigation covered 50 female patients with a clinical diagnosis of bacterial vaginosis. All patients were randomized into 2 groups: group 1 (25 patients) who received systemic nitroimidazole therapy, group 2 (25 patients) who received systemic nitroimidazole and clindamycin locally. For the diagnosis of BV, Amsel criteria are used. All patients were tested for real-time polymerase chain reaction (Inbioflor) and microbiological studies on the determination of the sensitivity of microorganisms to antibiotics. Control tests were carried out a month after treatment.
Results. DNA of Gardnerella vaginalis was detected in all women. Prevotella and Atopobium vaginae were most often detected. A microbiological examination revealed 15 species of conditionally pathogenic microorganisms, most commonly G. vaginalis and Escherichia coli were detected. A recurrence of the disease was detected in 20 % of cases (10 patients). In women with recurrence during the initial examination more than one microorganism was found, most often it was Prevotella, Atopobium, Streptococcus. In 9 patients more than one microorganism remains in the vagina after treatment.
Conclusion. In bacterial vaginosis there is a large species diversity of microflora. Requires additional antibiotic therapy aimed at concomitant microflora, which is not affected by standard drugs for the treatment of bacterial vaginosis.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Kira E.F. Bacterial vaginosis. M., 2012. 472 p. Russian (Кира Е.Ф. Бактериальный вагиноз. М.: ООО «Медицинское информационное агентство», 2012. 472 с.)
Fredricks DN, Fiedler TL, Thomas KK, Mitchell CM, Marrazzo JM. Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol. 2009; 47(3): 721-726
Srinivasan U, Ponnaluri S, Villareal L, Gillespie B, Wen A, Miles A et al. Gram stains: A resource for retrospective analysis of bacterial pathogens in clinical studies. PLoS ONE. 2012; 7(10): e42898. DOI: 10.1371/journal.pone.0042898
Kenyon C, Colebunders R, Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol. 2013; 209(6): 505-523
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2015; 64(33): 924
Hilbert DW, Smith WL, Paulish-Miller TE, Chadwick SG, Toner G, Mordechai E et al. Utilization of molecular methods to identify prognostic markers for recurrent bacterial vaginosis. Diagn Microbiol Infect Dis. 2016; 86(2): 231-242. DOI: 10.1016/j.diagmicrobio.2016.07.003
Hardy L, Jespers V, Abdellati S, De Baetselier I, Mwambarangwe L, Musengamana V et al. A fruitful alliance: the synergy between Atopobium vaginae and Gardnerella vaginalis in bacterial vaginosis-associated biofilm. Sex Transm Infect. 2016; 92(7): 487-491. DOI: 10.1136/sextrans-2015-052475
Verstraelen H, Swidsinski A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Curr Opin Infect Dis. 2013; 26(1): 86-89. DOI: 10.1097/QCO.0b013e32835c20cd
Machado A, Cerca N. Influence of biofilm formation by gardnerella vaginalis and other anaerobes on bacterial vaginosis. J Infect Dis. 2015; 212(12): 1856-1861. DOI.org/10.1093/infdis/jiv338
Shalepo KV, Nazarova VV, Menukhova YuN, Rumyantseva TA, Guschin AE, Savicheva AM. Assessment of current methods of laboratory diagnosis of bacterial vaginosis. Journal of Obstetrics and Women's Diseases. 2014; 63(1): 26-32. Russian (Шалепо К. В., Назарова В. В., Менухова Ю. Н., Румянцева Т. А., Гущин А. Е., Савичева А. М. Оценка современных методов лабораторной диагностики бактериального вагиноза //Журнал акушерства и женских болезней. 2014. T. 63, № 1. С. 26-32)
Machado A, Castro J, Cereija T, Almeida C, Cerca N. Diagnosis of bacterial vaginosis by a new multiplex peptide nucleic acid fluorescence in situ hybridization method. Peer J. 2015. 17(3). 780. DOI: 10.7717/peerj.780. eCollection 2015
Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL Jr, Martin DH. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect. Dis. 2004; 4: 5. DOI: 10.1186/1471-2334-4-5
De Backer E, Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Temmerman M, Vaneechoutte M. Antibiotic susceptibility of Atopobium vaginae. BMC Infect Dis. 2006; 6: 51. DOI: 10.1186/1471-2334-6-51
Alves P, Castro J, Sousa C, Cereija TB, Cerca N. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from BV patients in an in vitro biofilm formation model. J Infect Dis. 2014; 210(4): 593-596. DOI: 10.1093/infdis/jiu131
Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012; 66: 371-389. DOI: 10.1146/annurev-micro-092611-150157